Aplastic anemia is caused by how?

Written by Li Fang Fang
Hematology
Updated on September 05, 2024
00:00
00:00

The etiology of aplastic anemia is unclear. A more classical theory is the seed, soil, and bug theory. The seed theory suggests that patients with this condition have reduced hematopoietic stem cells in the bone marrow, leading to bone marrow failure. The soil theory refers to abnormal microenvironments in the bone marrow of patients, which leads to an abnormal growth environment for stem cells and consequently hematopoietic disturbances. The bug theory, which is commonly referred to in clinical settings as immune dysfunction, plays a major role in the etiology of this condition.

Other Voices

doctor image
home-news-image
Written by Zhang Xiao Le
Hematology
1min 13sec home-news-image

Are the liver and kidney functions normal in patients with aplastic anemia?

Patients with aplastic anemia generally have normal liver and kidney functions. However, in certain special circumstances, abnormalities in liver and kidney functions may occur, including: Firstly, the routine treatment for aplastic anemia mainly includes the immunosuppressant cyclosporine and the hematopoietic stimulant androgens. The primary side effect of cyclosporine is renal toxicity. Therefore, during the use of cyclosporine, it is necessary to monitor the concentration of cyclosporine; excessive levels can lead to renal dysfunction. Androgens, including stanozolol and danazol, primarily cause hepatic toxicity; hence, it is necessary to monitor liver and kidney functions during treatment of aplastic anemia. The second factor that may cause liver and kidney function abnormalities is severe anemia. Long-term severe anemia can lead to tissue ischemia and hypoxia in the liver or kidneys, and if prolonged, it can cause abnormalities in liver and kidney functions. (Medication use should be carried out under the guidance of a physician.)

doctor image
home-news-image
Written by Li Fang Fang
Hematology
59sec home-news-image

Does aplastic anemia cause fever?

Aplastic anemia itself does not cause fever in patients; however, individuals with aplastic anemia experience a decrease in all blood cells, including white blood cells, red blood cells, and platelets. A significant reduction in white blood cells, such as in a state of neutropenia, can lower a patient's resistance to infections, which makes it easy for secondary infections to occur and thus induce fever. Furthermore, in cases of severe anemia, severe aplastic anemia can also lead to the occurrence of low-grade fever in patients. On the other hand, a reduction in platelets generally does not cause fever. Therefore, when a patient with aplastic anemia has a fever, it is important to determine the cause of the fever.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
59sec home-news-image

What medicine is used to treat aplastic anemia?

Aplastic anemia is divided into acute aplastic anemia and chronic aplastic anemia. Patients with acute aplastic anemia require intensified immunotherapy or allogeneic hematopoietic stem cell transplantation from a sibling match. Intensified immunotherapy involves the simultaneous use of anti-thymocyte globulin (ATG) and cyclosporine. The main treatments for chronic aplastic anemia are immunosuppressive therapy and stimulative hematopoiesis therapy. Immunotherapy primarily involves oral administration of cyclosporine; stimulative hematopoiesis therapy may include oral administration of Chinese patent medicines such as Zao Zeng Xue Pian, and danazol, an anabolic steroid. (Medications should be used under the guidance of a doctor based on the specific circumstances.)

doctor image
home-news-image
Written by Li Fang Fang
Hematology
52sec home-news-image

How long can one live with aplastic anemia?

The lifespan of patients with aplastic anemia depends on the type and the effectiveness of the treatment. Aplastic anemia is classified into acute aplastic anemia and chronic aplastic anemia. In cases of acute aplastic anemia, cure is possible through intensified immunotherapy or hematopoietic stem cell transplantation; however, without aggressive treatment, the survival period is relatively short, generally not exceeding one year. Chronic aplastic anemia, on the other hand, has a longer medical history, and patients can often live for ten to twenty years or more. However, throughout this period, ongoing transfusions of red blood cells and platelets are required to support treatment.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
52sec home-news-image

Is aplastic anemia serious?

Whether aplastic anemia is severe depends on the specific circumstances of the aplastic anemia. Aplastic anemia can be divided into acute aplastic anemia and chronic aplastic anemia. Among them, acute aplastic anemia has a sudden onset, more severe clinical symptoms, and a higher mortality rate, so it is relatively more severe. Chronic aplastic anemia has a slower onset, and the degree of decrease in blood cells is relatively mild, also making it less severe. However, in cases of acute aplastic anemia, if intensive immunotherapy is administered, the effectiveness can reach 60%-70%, and it can be cured through hematopoietic stem cell transplantation.